Skip to Content

Latanoprost / Netarsudil Ophthalmic Dosage

Medically reviewed by Drugs.com. Last updated on Sep 28, 2020.

Applies to the following strengths: 0.005%-0.02%

Usual Adult Dose for Intraocular Hypertension

Latanoprost 0.005%-netarsudil 0.02% ophthalmic solution: 1 drop into the affected eye(s) once a day in the evening
-Maximum dose: 1 drop/eye/day

Comment: Administration of other topical ophthalmic drugs to lower intraocular pressure (IOP) should be separated by at least 5 minutes.

Use: Reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension

Usual Adult Dose for Glaucoma (Open Angle)

Latanoprost 0.005%-netarsudil 0.02% ophthalmic solution: 1 drop into the affected eye(s) once a day in the evening
-Maximum dose: 1 drop/eye/day

Comment: Administration of other topical ophthalmic drugs to lower intraocular pressure (IOP) should be separated by at least 5 minutes.

Use: Reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dose Adjustments

Missed doses:
-If a dose is missed, patients should continue with the next dose in the evening.
-The maximum daily dose is 1 drop in the affected eye per day.

Precautions

CONTRAINDICATIONS: None.

Safety and efficacy have not been established in pediatric patients.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
-During administration, patients should avoid touching tip of the single-use vial to the eye or any surface.
-Patients who require the use of other drugs to lower IOP should separate their administration by at least 5 minutes.

Storage requirements:
-The manufacturer product information should be consulted.

Patient advice:
-Patients should be instructed to avoid touching the vial tip to the eye or other surfaces.
-Patients who wear contact lenses should remove contact lenses before administration; the lenses may be reinserted at least 15 minutes after administration.
-Patients should be advised to speak to their healthcare provider if they become pregnant, intend to become pregnant, or are breastfeeding.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.